This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: 23Andme, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: I-Ling Chen: Innovator in Cancer Treatment
Introduction
I-Ling Chen is a notable inventor based in San Mateo, CA. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the interaction between ULBP6 and NKG2D, which has implications for cancer therapies.
Latest Patents
I-Ling Chen holds a patent for Anti-ULBP6 antibodies. This patent describes a ULBP6 binding protein that inhibits the interaction between ULBP6 and NKG2D. The methods outlined in this patent provide a potential avenue for treating cancer using the ULBP6 binding protein.
Career Highlights
I-Ling Chen is currently employed at 23andMe, Inc., where he continues to advance his research in biotechnology and cancer treatment. His work at this company reflects his commitment to innovation in the medical field.
Collaborations
I-Ling Chen has collaborated with notable colleagues such as Joel Benjamin and Shashank Bharill. These partnerships enhance the research and development efforts in their respective projects.
Conclusion
I-Ling Chen's contributions to cancer treatment through his patent and work at 23andMe, Inc. highlight his role as an influential inventor in the biotechnology sector. His innovative approaches continue to pave the way for advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile